loading
Schlusskurs vom Vortag:
$6.10
Offen:
$6.08
24-Stunden-Volumen:
115.03K
Relative Volume:
0.90
Marktkapitalisierung:
$353.40M
Einnahmen:
$34.16M
Nettoeinkommen (Verlust:
$-98.43M
KGV:
-2.7094
EPS:
-2.34
Netto-Cashflow:
$-119.33M
1W Leistung:
+9.31%
1M Leistung:
+34.32%
6M Leistung:
+45.08%
1J Leistung:
+0.79%
1-Tages-Spanne:
Value
$5.9401
$6.40
1-Wochen-Bereich:
Value
$5.717
$6.40
52-Wochen-Spanne:
Value
$2.9448
$10.25

Foghorn Therapeutics Inc Stock (FHTX) Company Profile

Name
Firmenname
Foghorn Therapeutics Inc
Name
Telefon
617-586-3100
Name
Adresse
500 TECHNOLOGY SQUARE, CAMBRIDGE
Name
Mitarbeiter
112
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-07
Name
Neueste SEC-Einreichungen
Name
FHTX's Discussions on Twitter

Vergleichen Sie FHTX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
FHTX
Foghorn Therapeutics Inc
6.34 323.30M 34.16M -98.43M -119.33M -2.34
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Foghorn Therapeutics Inc Stock (FHTX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-23 Eingeleitet Citizens JMP Mkt Outperform
2025-01-30 Eingeleitet B. Riley Securities Buy
2024-09-03 Eingeleitet Jefferies Buy
2024-08-19 Eingeleitet Evercore ISI Outperform
2023-03-28 Eingeleitet BofA Securities Buy
2023-01-05 Eingeleitet BMO Capital Markets Outperform
2021-11-22 Eingeleitet H.C. Wainwright Buy
2020-11-17 Eingeleitet Cowen Outperform
2020-11-17 Eingeleitet Goldman Buy
2020-11-17 Eingeleitet Morgan Stanley Overweight
2020-11-17 Eingeleitet Wedbush Outperform
Alle ansehen

Foghorn Therapeutics Inc Aktie (FHTX) Neueste Nachrichten

pulisher
02:52 AM

Trading (FHTX) With Integrated Risk Controls - news.stocktradersdaily.com

02:52 AM
pulisher
Jul 22, 2025

Foghorn Therapeutics Inc. Stock Analysis and ForecastBreakout stock performance - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Foghorn Therapeutics Inc. stockAccelerated capital growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Foghorn Therapeutics Inc. a good long term investmentFree Stock Market Trend Analysis - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Foghorn Therapeutics Inc. stock pricePhenomenal capital appreciation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Foghorn Therapeutics (NASDAQ:FHTX) Stock Price Down 0.5% – What’s Next? - Defense World

Jul 22, 2025
pulisher
Jul 21, 2025

Why Foghorn Therapeutics Inc. stock attracts strong analyst attentionTriple Return With Stability - Newser

Jul 21, 2025
pulisher
Jul 19, 2025

SAIL Stock Analysis and ForecastFree Trading Psychology Coaching - Jammu Links News

Jul 19, 2025
pulisher
Jul 19, 2025

What analysts say about Leonardo DRS Inc. stockMarket-beating performance - Jammu Links News

Jul 19, 2025
pulisher
Jul 15, 2025

What makes Foghorn Therapeutics Inc. stock price move sharplyHigh Potential Safe Trades - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Foghorn Therapeutics Inc. stock performs during market volatilityConsistent Win Signals - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

(FHTX) Trading Report - news.stocktradersdaily.com

Jul 12, 2025
pulisher
Jul 10, 2025

Foghorn Therapeutics Inc.'s (NASDAQ:FHTX) Shares May Have Run Too Fast Too Soon - simplywall.st

Jul 10, 2025
pulisher
Jul 02, 2025

(FHTX) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Jul 02, 2025
pulisher
Jul 02, 2025

112-employee biotech leaves Cambridge HQ for Watertown - The Business Journals

Jul 02, 2025
pulisher
Jul 01, 2025

Foghorn Therapeutics Signs New Lease Agreement - TipRanks

Jul 01, 2025
pulisher
Jun 29, 2025

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

Jun 29, 2025
pulisher
Jun 25, 2025

Exchange Traded Concepts LLC Grows Holdings in Foghorn Therapeutics Inc. (NASDAQ:FHTX) - Defense World

Jun 25, 2025
pulisher
Jun 21, 2025

When the Price of (FHTX) Talks, People Listen - news.stocktradersdaily.com

Jun 21, 2025
pulisher
Jun 17, 2025

Foghorn Therapeutics Holds Successful Annual Meeting - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

Bank of America Corp DE Has $149,000 Stock Position in Foghorn Therapeutics Inc. (NASDAQ:FHTX) - Defense World

Jun 17, 2025
pulisher
Jun 13, 2025

Soft Tissue Sarcoma Pipeline 2025: MOA, ROA, FDA-Approved Drugs, And Clinical Trial Progress Assessment By Delveinsight Oncotherapy Science, Foghorn Therapeutics, C4 Therapeutics, Lyvgen Biopharma - MENAFN.com

Jun 13, 2025
pulisher
Jun 11, 2025

Soft Tissue Sarcoma Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | OncoTherapy Science, Foghorn Therapeutics, C4 Therapeutics, Lyvgen Biopharma - Barchart.com

Jun 11, 2025
pulisher
Jun 11, 2025

Trend Tracker for (FHTX) - news.stocktradersdaily.com

Jun 11, 2025
pulisher
Jun 10, 2025

Millennium Management LLC Raises Stock Position in Foghorn Therapeutics Inc. (NASDAQ:FHTX) - Defense World

Jun 10, 2025
pulisher
Jun 08, 2025

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Shares Acquired by Wellington Management Group LLP - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives $12.13 Consensus Target Price from Analysts - Defense World

Jun 07, 2025
pulisher
Jun 03, 2025

BNP Paribas Financial Markets Makes New $61,000 Investment in Foghorn Therapeutics Inc. (NASDAQ:FHTX) - Defense World

Jun 03, 2025
pulisher
May 29, 2025

Northern Trust Corp Purchases 2,873 Shares of Foghorn Therapeutics Inc. (NASDAQ:FHTX) - Defense World

May 29, 2025
pulisher
May 26, 2025

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Position Increased by D. E. Shaw & Co. Inc. - Defense World

May 26, 2025
pulisher
May 26, 2025

Lazard Asset Management LLC Acquires New Shares in Foghorn Therapeutics Inc. (NASDAQ:FHTX) - Defense World

May 26, 2025
pulisher
May 22, 2025

Foghorn Therapeutics Inc. to Participate in Major Upcoming Healthcare Conferences in 2025 - Nasdaq

May 22, 2025
pulisher
May 22, 2025

Foghorn Therapeutics to Participate in Four Upcoming Investor Conferences - GlobeNewswire

May 22, 2025
pulisher
May 20, 2025

10,895 Shares in Foghorn Therapeutics Inc. (NASDAQ:FHTX) Acquired by Cubist Systematic Strategies LLC - Defense World

May 20, 2025

Finanzdaten der Foghorn Therapeutics Inc-Aktie (FHTX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):